Semaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits
We have read the article published by Kadowaki, et al. 1 “Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes mellitus in an East Asian population (STEP 6): A randomized, double blind, double dummy, placebo controlled, phase 3a trial”, where the authors conc...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Asociación Colombiana de Nefrología e Hipertensión Arterial
2022-10-01
|
| Series: | Revista Colombiana de Nefrología |
| Subjects: | |
| Online Access: | https://www.revistanefrologia.org/index.php/rcn/article/view/614 |